1. Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial
2. Jamali F, Lemery S, Ayalew K, Robottom S, Robie-Suh K, Rieves D, et al. Romiplostim for the treatment of chronic immune (idiopathic) thrombocytopenic purpura. Oncology (Williston Park) 2009;23(8):704-9.
3. Waknine Y. FDA Approvals: omacor, nuflexxa, combunox, and others. Medscape Today: http://www. medscape. com/viewarticle/495709. Última Visita 2004;18.
4. Generic romiplostim for children with persistent or chronic immune thrombocytopenia: Experience from a tertiary care centre in North India
5. An Introduction to Genetic Engineering